Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study (Q57100999)
Jump to navigation
Jump to search
scientific article published on 18 June 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study |
scientific article published on 18 June 2018 |
Statements
Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study (English)
Sumathi Sivapalasingam
Mohamed Kamal
Rabih Slim
Romana Hosain
Weiping Shao
Randall Stoltz
Joseph Yen
Laura G Pologe
Yuan Cao
Michael Partridge
Giane Sumner